Evidence map›Paper›PMID 35203522›Full record

ArticleBiomedicines2022

Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Harbor Short and Unstable Telomeres Leading to Chromosomal Instability.

Radhia M'Kacher, Madeleine Jaillet, Bruno Colicchio, Eirini Vasarmidi, Arnaud Mailleux, Alain Dieterlen, Caroline Kannengiesser, Claire Borie, Noufissa Oudrhiri, Steffen Junker and 7 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  2. Review
  3. Insights into interstitial lung disease pathogenesis.Breathe (Sheffield, England) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Radhia M'KacherCell Environment DNA Damage R&D, Genopole, F-91058 Evry, France.
Madeleine JailletInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.
Bruno ColicchioIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, F-68100 Mulhouse, France.ORCID 0000-0002-1742-8631
Eirini VasarmidiInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.
Arnaud MailleuxInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.
Alain DieterlenIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, F-68100 Mulhouse, France.
Caroline KannengiesserInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.
Claire BorieAPHP-Service D'Hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay, Inserm UMR 935, F-94801 Villejuif, France.
Noufissa OudrhiriAPHP-Service D'Hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay, Inserm UMR 935, F-94801 Villejuif, France.
Steffen JunkerInstitute of Biomedicine, University of Aarhus, DK-8000 Aarhus, Denmark.
Philippe VoisinCell Environment DNA Damage R&D, Genopole, F-91058 Evry, France.
Eric JeandidierLaboratoire de Génétique, Groupe Hospitalier de la Région de Mulhouse Sud-Alsace, F-68100 Mulhouse, France.ORCID 0000-0002-2757-0770
Patrice CardeDepartment of Hematology, Gustave Roussy Cancer Campus, F-94801 Villejuif, France.
Michael FenechSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-8466-0991
Annelise Bennaceur-GriscelliAPHP-Service D'Hématologie-Oncohématologie Moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay, Inserm UMR 935, F-94801 Villejuif, France.
Bruno CrestaniInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.ORCID 0000-0002-2961-3455
Raphael BorieInserm U1152, Laboratoire d'Excellence INFLAMEX, Université de Paris, F-75018 Paris, France.ORCID 0000-0002-9906-0024
Inserm · FRGenopole (France) · FRUniversité de Haute-Alsace · FRAarhus University · DKGroupe Hospitalier de la Région de Mulhouse et Sud Alsace · FRInstitut Gustave Roussy · FRUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is associated with several hallmarks of aging including telomere shortening, which can result from germline mutations in telomere related genes (TRGs). Here, we assessed the length and stability of telomeres as well as the integrity of chromosomes in primary lung fibroblasts from 13 IPF patients (including seven patients with pathogenic variants in TRGs) and seven controls. Automatized high-throughput detection of telomeric FISH signals highlighted lower signal intensity in lung fibroblasts from IPF patients, suggesting a telomere length defect in these cells. The increased detection of telomere loss and terminal deletion in IPF cells, particularly in TRG-mutated cells (IPF-TRG), supports the notion that these cells have unstable telomeres. Furthermore, fibroblasts from IPF patients with TRGs mutations exhibited dicentric chromosomes and anaphase bridges. Collectively, our study indicates that fibroblasts from IPF patients exhibit telomere and chromosome instability that likely contribute to the physiopathology.

Indexed as

anaphase bridgesdicentric chromosomeidiopathic pulmonary fibrosismicronucleiRTEL1telomere dysfunctionTERT

Identifiers

PMID35203522
PMCPMC8869717
OpenAlexW4210275611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.